Corizon Health Doctor Recognized for “Bold Experiment” in Philadelphia’s Women’s Prison

A medication-assisted treatment program in the Philadelphia’s Riverside Correctional Facility, the city’s prison for women, is being recognized for helping to protect women from heroin overdoses when they are released.

On Monday, August 6, 2018, stories in The Inquirer and on WHYY, Philadelphia’s public broadcasting station, highlighted the jail’s MAT program, which provides patients with a low dose of an opioid-based medication to reduce cravings and withdrawal symptoms and maintain a minimum tolerance so they don’t overdose should they return to using heroin upon release.

Dr. Jon Lepley, Corizon Health’s Chief Medical Officer for the facility, pioneered the program in partnership with the City of Philadelphia’s Prison Department, after learning about patients who overdosed and died soon after leaving jail.

The program piggybacks on an effort to provide the overdose-reversing drug naloxone to inmates as they leave the facility.

You can read more about the program and Dr. Lepley at this link.